Iveric Bio has received permanent J-code from CMS for its GA treatment, Izervay (avacincaptad pegol intravitreal solution), a significant advancement for patients with GA secondary to AMD.
Provectus Secures Global Licensing Agreement for Eye Infection TreatmentMar 28, 2024Provectus Biopharmaceuticals has signed an exclusive global licensing agreement with the University of Miami to harness the University’s pioneering photodynamic antimicrobial therapy for combating (acanthamoeba) eye infections.
Don't Miss Out: ASCRS Congress 2024 Kicks Off This April 5-8Mar 28, 2024From April 5 to 8, 2024, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting is set to take place in Boston, USA, at the Boston Convention & Exhibition Center.
ABVC BioPharma Announces Global Licensing Agreement with ForSeeCon Mar 28, 2024ABVC BioPharma, Inc. has entered into a significant global licensing agreement with ForSeeCon Eye Corporation, marking a pivotal moment for the clinical-stage biopharmaceutical company known for its developments in ophthalmology, CNS, and oncology.
Researchers Discover a Protein That Can Repair Optic Nerve DamageMar 27, 2024Researchers at the University of Connecticut (UConn) have identified a potentially transformative factor for regenerating damaged optic nerves, which could ultimately prevent irreversible blindness.
The Serious Impact of Smoking on Your Eye Health Mar 25, 2024Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, stroke as well as eye diseases.